By
Bill Fisher
| October 21st, 2020
What we discovered is we could detect this toxin in post mortem brain tissue – brains that were donated for research – from Alzheimer’s disease patients. There was a rather high frequency of detection as a matter of fact, only incidental detection in people who were unaffected healthy controls. And we also found it in ALS, but we didn’t see it in Huntington’s.